GHK-Cu vs LL-37

Side-by-side comparison of GHK-Cu, LL-37 — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute GHK-Cu Glycyl-L-Histidyl-L-Lysine Copper Complex Recovery LL-37 LL-37 (Human Cathelicidin Antimicrobial Peptide) Recovery
Basics
Molecular type Copper-Binding TripeptideHuman Cathelicidin
Amino acids 337
Molecular weight 340.4 Da4,493.3 Da
Half-life Short (minutes to hours)Short (hours)
Route(s) Subcutaneous, Topical (skin), IV (research)Subcutaneous, Topical, Intranasal
Mechanism & Research
Primary mechanism GHK-Cu forms a stable complex with copper(II), which is essential for its biological activity. The copper complex activates collagenase and other metalloproteinases that remodel damaged extracellular matrix while simulta… LL-37 disrupts microbial membranes through electrostatic interaction — its cationic amphipathic helical structure inserts into negatively charged bacterial membranes, causing lethal membrane permeabilisation. This mechan…
Research status Research Compound Research Compound
Evidence summary GHK-Cu is one of the most thoroughly researched cosmetic and wound-healing peptides. Topical GHK-Cu is commercially used in skincare. Deeper systemic applications (anti-aging, neuroprotection, systemic collagen support) … LL-37 has been studied extensively for wound healing, respiratory infections (including COVID-19 lung immunity), and more recently for senolytic applications. Its broad antimicrobial and immunomodulatory profile makes it…
Protocol & Dosing
Typical dose 1–2 mg/day (SC); topical as needed1–5 mg per injection or topical application
Frequency DailyDaily
Duration 8–12 weeks4–8 weeks
Timing Any time of dayAny time
Safety
Common side effects
  • Topical: mild skin irritation at application site
  • Injectable: injection site redness
  • Copper taste (topical — rare)
  • Injection site pain (cytokine release)
  • Mild erythema
  • Headache (rare)
Contraindications
  • Wilson's disease (copper metabolism disorder)
  • Known copper sensitivity
  • Pregnancy (insufficient systemic safety data)
  • Autoimmune conditions (immune stimulation)
  • Active lupus (LL-37 is a lupus autoantigen in some patients)
  • Pregnancy (no data)
Anti-doping Not Prohibited Not Prohibited
Deeper reading
Related peptides BPC-157, Epithalon, LL-37 BPC-157, GHK-Cu, KPV
Full profile Read full GHK-Cu profile → Read full LL-37 profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.